Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.
Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.
复制标题
使用 PEP-C 治疗的非霍奇金淋巴瘤患者的隐球菌骨髓炎和脑膜炎。
DOI:
10.1136/bcr.08.2011.4578
复制
发表时间:
2012
期刊:
影响因子:
0.9
通讯作者:
Fan,AliceC
中科院分区:
文献类型:
--
作者:
To,ChristinaA;Hsieh,RobertW;McClellan,JamesScott;Howard,Walter;Fischbein,NancyJ;Brown,JaniceMY;Felsher,DeanW;Fan,AliceC
We present the first case report of a lymphoma patient who developed disseminated cryptococcal osteomyelitis and meningitis while being treated with the PEP-C (prednisone, etoposide, procarbazine and cyclophosphamide) chemotherapy regimen. During work-up of fever and new bony lesions, fungal culture from a rib biopsy revealed that the patient had cryptococcal osteomyelitis. Further evaluation demonstrated concurrent cryptococcal meningitis. The patient’s disseminated cryptococcal infections completely resolved after a full course of antifungal treatment. Cryptococcal osteomyelitis is itself an extremely rare diagnosis, and the unique presentation with concurrent cryptococcal meningitis in our patient with lymphoma was likely due to his PEP-C treatment. It is well recognized that prolonged intensive chemotherapeutic regimens place patients at risk for atypical infections; yet physicians should recognize that even chronic low-dose therapies can put patients at risk for fungal infections. Physicians should consider fungal infections as part of the infectious work up of a lymphopenic patient on PEP-C.